{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:52:23Z","timestamp":1777949543520,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mechanisms by which MiRNA-141 promotes lung fibrosis in ARDS rats through activation of the Keap1-Nrr2\/ARE signaling pathway","award":["No.82160021"],"award-info":[{"award-number":["No.82160021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00820-0","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:33:01Z","timestamp":1774420381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical significance of miR-548a-3p and its potential role in acute respiratory distress syndrome complicated with pulmonary fibrosis via OSM"],"prefix":"10.1186","volume":"27","author":[{"given":"Siyu","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongpeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunling","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwen","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"820_CR1","doi-asserted-by":"publisher","first-page":"107883","DOI":"10.1016\/j.cct.2025.107883","volume":"153","author":"G Monti","year":"2025","unstructured":"Monti G, Marzaroli M, Tucciariello MT, Ferrara B, Meroi F, Nakhnoukh C, Zambon M, Borghi G, Guarracino F, Manazza M, et al. Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol. Contemp Clin Trials. 2025;153:107883.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"820_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13019-025-03511-w","volume":"20","author":"L Chen","year":"2025","unstructured":"Chen L, Zhuang Q. Expression level, correlation, and diagnostic value of serum miR-99a in pulmonary fibrosis in patients with acute respiratory distress syndrome. J Cardiothorac Surg. 2025;20(1):276.","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"820_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-024-02795-1","volume":"25","author":"G Gazzaniga","year":"2024","unstructured":"Gazzaniga G, Voltini M, Carletti A, Lenta E, Meloni F, Briganti DF, Avanzini MA, Comoli P, Belliato M. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis. Respir Res. 2024;25(1):170.","journal-title":"Respir Res"},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2022.12.006","volume":"53","author":"XZ Fang","year":"2023","unstructured":"Fang XZ, Li M, Wang YX, Zhang P, Sun MM, Xu JX, Yang YY, He YJ, Yu Y, Li RT, et al. Mechanosensitive ion channel Piezo1 mediates mechanical ventilation-exacerbated ARDS-associated pulmonary fibrosis. J Adv Res. 2023;53:175\u201386.","journal-title":"J Adv Res"},{"issue":"12","key":"820_CR5","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","volume":"29","author":"T Koudstaal","year":"2023","unstructured":"Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS. Pulmonary fibrosis: from pathogenesis to clinical decision-making. Trends Mol Med. 2023;29(12):1076\u201387.","journal-title":"Trends Mol Med"},{"issue":"1","key":"820_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s41065-025-00436-1","volume":"162","author":"X Huang","year":"2025","unstructured":"Huang X, Xu P, Long G, Huang F, Zhang Q, Yang X, Sun H, Ji C, Liu W. Clinical significance of miR-6515-5p in predicting diagnosis and prognosis for acute respiratory distress syndrome suffering from pulmonary fibrosis. Hereditas. 2025;162(1):71.","journal-title":"Hereditas"},{"issue":"5","key":"820_CR7","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451\u201365.","journal-title":"J Cell Physiol"},{"issue":"4","key":"820_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"820_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ncrna.2023.08.006","volume":"8","author":"J Jiang","year":"2023","unstructured":"Jiang J, Guo F, Li W, Shan X. miR-346 regulates the development of ARDS by regulating the function of pulmonary microvascular endothelial cells. Noncoding RNA Res. 2023;8(4):579\u201388.","journal-title":"Noncoding RNA Res"},{"key":"820_CR10","doi-asserted-by":"publisher","first-page":"105428","DOI":"10.1016\/j.tiv.2022.105428","volume":"84","author":"ES Son","year":"2022","unstructured":"Son ES, Ko UW, Jeong HY, Park SY, Lee YE, Park JW, Jeong SH, Kim SH, Kyung SY. miRNA-6515-5p regulates particulate matter-induced inflammatory responses by targeting CSF3 in human bronchial epithelial cells. Toxicol Vitro. 2022;84:105428.","journal-title":"Toxicol Vitro"},{"issue":"6","key":"820_CR11","first-page":"635","volume":"76","author":"C Zhang","year":"2022","unstructured":"Zhang C, Ji Y, Wang Q, Ruan L. MiR-338-3p Is a Biomarker in Neonatal Acute Respiratory Distress Syndrome (ARDS) and Has Roles in the Inflammatory Response of ARDS Cell Models. Acta Med Okayama. 2022;76(6):635\u201343.","journal-title":"Acta Med Okayama"},{"issue":"10","key":"820_CR12","first-page":"917","volume":"37","author":"M Wang","year":"2022","unstructured":"Wang M, Yang M, Deng B. miR-548a-3p Weakens the Tumorigenesis of Colon Cancer Through Targeting TPX2. Cancer Biother Radiopharm. 2022;37(10):917\u201326.","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"820_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/bmm-2017-0224","volume":"12","author":"M Matboli","year":"2018","unstructured":"Matboli M, Shafei AE, Azazy AE, Reda M, El-Khazragy N, Nagy AA, Ali MA, Sobhi M, Abdel-Rahman O. Clinical evaluation of circulating miR-548a-3p and \u2013\u200920a expression in malignant pleural mesothelioma patients. Biomark Med. 2018;12(2):129\u201339.","journal-title":"Biomark Med"},{"key":"820_CR14","doi-asserted-by":"crossref","unstructured":"Bueno LCM, Paim LR, Minin EOZ, da Silva LM, Mendes PR, Kiyota TA, Schreiber AZ, Bombassaro B, Mansour E, Moretti ML, et al. Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19. Viruses. 2022;14(7):1363.","DOI":"10.3390\/v14071363"},{"issue":"23","key":"820_CR15","first-page":"2526","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333.","journal-title":"JAMA"},{"issue":"6","key":"820_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.21037\/atm-22-979","volume":"10","author":"D Zhu","year":"2022","unstructured":"Zhu D, Zhou M, Wang K, Hu X, Gong L, Luo H, Zhou X, Hu J. The downregulation of miR-129-5p relieves the inflammatory response in acute respiratory distress syndrome by regulating PPARgamma-mediated autophagy. Ann Transl Med. 2022;10(6):345.","journal-title":"Ann Transl Med"},{"issue":"2","key":"820_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1165\/rcmb.2021-0358OC","volume":"66","author":"CD Russell","year":"2022","unstructured":"Russell CD, Valanciute A, Gachanja NN, Stephen J, Penrice-Randal R, Armstrong SD, Clohisey S, Wang B, Al Qsous W, Wallace WA, et al. Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19. Am J Respir Cell Mol Biol. 2022;66(2):196\u2013205.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"820_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1620\/tjem.2023.J093","volume":"262","author":"G Long","year":"2024","unstructured":"Long G, Zhang Q, Yang X, Sun H, Ji C. Diagnostic and Predictive Significance of Serum MiR-141-3p in Acute Respiratory Distress Syndrome Patients with Pulmonary Fibrosis. Tohoku J Exp Med. 2024;262(3):157\u201362.","journal-title":"Tohoku J Exp Med"},{"key":"820_CR19","doi-asserted-by":"publisher","first-page":"118286","DOI":"10.1016\/j.biopha.2025.118286","volume":"189","author":"J Liao","year":"2025","unstructured":"Liao J, Liang Y, Liu Z, Xie Q, Zhang JM, Song SY, Huang X, Cao L, Wang Y. Pyroptosis in acute respiratory distress syndrome and pulmonary fibrosis. Biomed Pharmacother. 2025;189:118286.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"820_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s11033-024-10047-0","volume":"51","author":"S Zhang","year":"2024","unstructured":"Zhang S, Rong L, Long G, Huang F, Zhang Q, Yang X, Sun H, Ji C, Ye RH. Clinical significance and potential mechanism of hsa_circ_0006892 in acute respiratory distress syndrome complicated with pulmonary fibrosis. Mol Biol Rep. 2024;51(1):1120.","journal-title":"Mol Biol Rep"},{"key":"820_CR21","doi-asserted-by":"publisher","first-page":"1239732","DOI":"10.3389\/fimmu.2023.1239732","volume":"14","author":"CL Wolf","year":"2023","unstructured":"Wolf CL, Pruett C, Lighter D, Jorcyk CL. The clinical relevance of OSM in inflammatory diseases: a comprehensive review. Front Immunol. 2023;14:1239732.","journal-title":"Front Immunol"},{"key":"820_CR22","doi-asserted-by":"publisher","first-page":"107158","DOI":"10.1016\/j.intimp.2020.107158","volume":"90","author":"A Masjedi","year":"2021","unstructured":"Masjedi A, Hajizadeh F, Beigi Dargani F, Beyzai B, Aksoun M, Hojjat-Farsangi M, Zekiy A, Jadidi-Niaragh F. Oncostatin M: A mysterious cytokine in cancers. Int Immunopharmacol. 2021;90:107158.","journal-title":"Int Immunopharmacol"},{"issue":"25","key":"820_CR23","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.2174\/1381612823666170704122559","volume":"23","author":"JM Stephens","year":"2017","unstructured":"Stephens JM, Elks CM. Oncostatin M: Potential Implications for Malignancy and Metabolism. Curr Pharm Des. 2017;23(25):3645\u201357.","journal-title":"Curr Pharm Des"},{"key":"820_CR24","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhu D, Wei L, Zhao Z, Qi X, Li Z, Sun D. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction. Biomed Res Int. 2015:2015:317905.","DOI":"10.1155\/2015\/317905"},{"issue":"6756","key":"820_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.adi8828","volume":"389","author":"DA Hoagland","year":"2025","unstructured":"Hoagland DA, Rodriguez-Morales P, Mann AO, Baez Vazquez AY, Yu S, Lai A, Kane H, Dang SM, Lin Y, Thorens L, et al. Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage. Science. 2025;389(6756):169\u201375.","journal-title":"Science"},{"issue":"10","key":"820_CR26","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.4049\/jimmunol.181.10.7243","volume":"181","author":"A Mozaffarian","year":"2008","unstructured":"Mozaffarian A, Brewer AW, Trueblood ES, Luzina IG, Todd NW, Atamas SP, Arnett HA. Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J Immunol. 2008;181(10):7243\u201353.","journal-title":"J Immunol"},{"issue":"12","key":"820_CR27","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1111\/aor.14619","volume":"47","author":"H Setiadi","year":"2023","unstructured":"Setiadi H, El-Banayosy AM, Long JW, Maybauer MO, Mihu MR, El Banayosy A. Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients. Artif Organs. 2023;47(12):1885\u201392.","journal-title":"Artif Organs"},{"issue":"1","key":"820_CR28","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1038\/s41598-017-13511-z","volume":"7","author":"EA Ayaub","year":"2017","unstructured":"Ayaub EA, Dubey A, Imani J, Botelho F, Kolb MRJ, Richards CD, Ask K. Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis. Sci Rep. 2017;7(1):13281.","journal-title":"Sci Rep"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00820-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:54:20Z","timestamp":1777856060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00820-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00820-0","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Guizhou Provincial People\u2019s Hospital. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}